Laparoscopy
surgical robot is used in laparoscopy surgeries.Laparoscopy is a minimally
persistent surgical procedure which supports in the diagnosis of many abdominal
& pelvic disorders, for instance cysts, fibroid, adhesion and infection
that occurs in the female pelvic organs. Some of the key equipment are used in
this surgery such as routing systems, robot machines, simulators & planners
and others. This surgical robot provides 3 dimensional or 3D visualization of function
field, decrease fatigue & tension tremor of the doctor and added wrist
movement for enhanced dexterity and superior surgical precision.
The major
associated benefits are shorter hospital stay, reduced recovery time, less risk
of infection, reduced trauma to the body, less blood loss and less scarring.
Additionally, some of the other possible complications include bleeding, damage
to neighboring organs or structures, anesthesia related problems and infection
etc. Moreover, few factors which may augment the risk of complications include
diabetes, smoking, obesity, use of certain medications, pre-existing heart or
lung condition, previous abdominal or pelvic surgery, excessive alcohol intake
and use of certain medications.
According to
study, “Global Laparoscopy Surgical
Robots Market by Surgery, Product, Equipment Type and Region 2016-2025” some of the major companies
that are currently working in the global laparoscopy surgical robots market are Brainlab
AG, Curexo Technology Corp., CAE Healthcare, Hitachi Medical Corp., Mazor
Robotics Ltd., Intuitive Surgical, Medtronic Inc., Kinamed Inc., Merge
Healthcare, MAKO, Simbionix USA Corp., Medrobotics Corporation, Siemens
Healthineers, Stryker Corp., Smith & Nephew PLC, Think Surgical, Inc., SONOWAND
AS, Titan Medical, Surgical Science AB, VOXEL-MAN.
Based on surgery,
global laparoscopy surgical robot market is segmented into cholecystectomy,
nephrectomy, bariatric surgery, adrenalectomy, colectomy, appendectomy,
nephrectomy, hernia repair, hysterectomy, nissen fundoplication, myomectomy,
prostatectomy, pyloroplasty and hernia repair etc. Based on procedure of tests,
market is segmented into blood tests, CT scan, ECG, physical exam, x-ray of
kidneys (bladder & ureter), urine tests, abdominal or pelvic ultrasound and
intravenous pyelogram (IVP). Based on type of procedure, market is segmented
into local anesthesia and general anesthesia. General anesthesia blocks pain &
keeps asleep during the surgery.
The global
laparoscopy surgical robots is primarily driven by improved access to medical
services, followed by rapid technological advancements in healthcare industry, increasing
demand for healthcare facilities, increasingly geriatric worldwide populations,
rising chronic disease rates and increasing demand for minimally invasive
surgeries. Recent technological advancements have enhanced digital imaging
competences at surgical sites, enabling intensification up to 20 times the definite
size, in turn allowing surgeons to work with more precision. In addition, some
of the other hampering factors are lack of trained surgical professionals, lack
of reimbursement in the emerging markets, and a high learning curve for device
use.
The laparoscopic
procedures achieved significant momentum and are further driven by a trend to
laparoscopic-based bariatric surgery. In 2017, above 21 million procedures were
completed in the US, followed by Japan with 13.4 million and China with 16.8
million procedures annually. During the period 2017-2025, it is expected that the global demand for laparoscopy surgical robots to grow by 7.7% per annum
in provisions of annual revenue. It is also expected that the global market to
grow progressively due to the rising applications of laparoscopy-based robotic
solutions in urological, cardiac, gynecological, gastrointestinal and
ear/nose/throat (ENT) surgery across the world.
To know more, click on the link below:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
